Professional stigma towards clients with methamphetamine use disorder – a qualitative study

References

• Ahmedani, B. K. (2011). Mental health stigma: Society, individuals, and the profession. Journal of Social Work Values and Ethics, 8(2), 41–416.
   PubMedGoogle Scholar
• American Psychiatric, A. (2013). Diagnostic and statistical manual of mental disorders (DSM-5®). American Psychiatric Publishing. http://ebookcentral.proquest.com/lib/usyd/detail.action?docID=1811753
   Google Scholar
• Bell, C. A. F., & McCurry, M. (2020). Opioid use disorder education for acute care nurses: An integrative review. Journal of Clinical Nursing, 29(17-18s), 3122–3135. https://doi.org/10.1111/jocn.15372
   PubMed Web of Science ®Google Scholar
• Bheekie, A., Van Huyssteen, M., & Coetzee, R. (2019). Exploring the implications of a needs-based pharmacy education framework modelled on population health: Perspective from a developing country. Pharmacy, 7(3), 116. https://doi.org/10.3390/pharmacy7030116
   Web of Science ®Google Scholar
• Bonn, M., Palayew, A., Bartlett, S., Brothers, T. D., Touesnard, N., & Tyndall, M. (2020). Addressing the syndemic of HIV, hepatitis C, overdose, and COVID-19 Among people Who Use drugs: The potential roles for decriminalization and safe supply. Journal of Studies on Alcohol and Drugs, 81(5), 556–560. https://doi.org/10.15288/jsad.2020.81.556
   PubMed Web of Science ®Google Scholar
• Boydell, V., McMullen, H., Cordero, J., Steyn, P., & Kiare, J. (2019). Studying social accountability in the context of health system strengthening: innovations and considerations for future work. Health Research Policy and Systems, 17(1), 34. https://doi.org/10.1186/s12961-019-0438-x
   PubMedGoogle Scholar
• Brener, L., von Hippel, W., & Kippax, S. (2007). Prejudice among health care workers toward injecting drug users with hepatitis C: Does greater contact lead to less prejudice? International Journal of Drug Policy, 18(5), 381–387. https://doi.org/10.1016/j.drugpo.2007.01.006
   PubMed Web of Science ®Google Scholar
• Brouwers, E. P. M. (2020). Social stigma is an underestimated contributing factor to unemployment in people with mental illness or mental health issues: position paper and future directions. BMC Psychology, 8(1), 36. https://doi.org/10.1186/s40359-020-00399-0
   PubMed Web of Science ®Google Scholar
• Chaar, B. B., Hanrahan, J. R., & Day, C. (2011). Provision of opioid substitution therapy services in Australian pharmacies. Australasian Medical Journal, 4(4), 210–216. https://doi.org/10.4066/AMJ.2011.706
   PubMedGoogle Scholar
• Chaar, B. B., Wang, H., Day, C. A., Hanrahan, J. R., Winstock, A. R., & Fois, R. (2013). Factors influencing pharmacy services in opioid substitution treatment. Drug and Alcohol Review, 32(4), 426–434. https://doi.org/10.1111/dar.12032
   PubMed Web of Science ®Google Scholar
• Chalmers, J., Lancaster, K., & Hughes, C. (2016). The stigmatisation of ‘ice’ and under-reporting of meth/amphetamine use in general population surveys: A case study from Australia. International Journal of Drug Policy, 36, 15–24. https://doi.org/10.1016/j.drugpo.2016.06.001
   PubMed Web of Science ®Google Scholar
• Chapman, E. N., Kaatz, A., & Carnes, M. (2013). Physicians and implicit bias: How doctors May unwittingly perpetuate health care disparities. Journal of General Internal Medicine, 28(11), 1504–1510. https://doi.org/10.1007/s11606-013-2441-1
   PubMed Web of Science ®Google Scholar
• Childress, J. F., & Beauchamp, T. L. (1994). Principles of biomedical ethics. Oxford University Press.
   Google Scholar
• Cohn, A., O'Connor, R., Lancaster, K., Rawstorne, P., & Nathan, S. (2020). Media and political framing of crystal methamphetamine use in Australia. Drugs: Education, Prevention and Policy, 27(4), 261–270. https://doi.org/10.1080/09687637.2019.1679089
   Web of Science ®Google Scholar
• Cook, J. E., Purdie-Vaughns, V., Meyer, I. H., & Busch, J. T. A. (2014). Intervening within and across levels: A multilevel approach to stigma and public health. Social Science & Medicine, 103, 101–109. https://doi.org/10.1016/j.socscimed.2013.09.023
   PubMed Web of Science ®Google Scholar
• Corbin, J., & Strauss, A. (2014). Basics of qualitative research: Techniques and procedures for developing grounded theory. SAGE Publications. https://books.google.com.au/books?id=hZ6kBQAAQBAJ
   Google Scholar
• Corrigan, P. W., & Watson, A. C. (2002a). The paradox of self-stigma and mental illness. Clinical Psychology: Science and Practice, 9(1), 35–53. https://doi.org/10.1093/clipsy.9.1.35
   Web of Science ®Google Scholar
• Corrigan, P. W., & Watson, A. C. (2002b). Understanding the impact of stigma on people with mental illness. World Psychiatry, 1(1), 16–20.
   PubMedGoogle Scholar
• Crocker, J. (1999). Social stigma and self-esteem: Situational construction of self-worth. Journal of Experimental Social Psychology, 35(1), 89–107. https://doi.org/10.1006/jesp.1998.1369
   Web of Science ®Google Scholar
• Davis, S., Wallace, B., Van Roode, T., & Hore, D. (2022). Substance Use stigma and community drug checking: A qualitative study examining barriers and possible responses. International Journal of Environmental Research and Public Health, 19(23), 15978. https://doi.org/10.3390/ijerph192315978
   PubMed Web of Science ®Google Scholar
• Deen, H., Kershaw, S., Newton, N., Stapinski, L., Birrell, L., Debenham, J., Champion, K. E., Kay-Lambkin, F., Teesson, M., & Chapman, C. (2021). Stigma, discrimination and crystal methamphetamine (‘ice’): Current attitudes in Australia. International Journal of Drug Policy, 87, 102982. https://doi.org/10.1016/j.drugpo.2020.102982
   PubMed Web of Science ®Google Scholar
• Degenhardt, L., Sara, G., McKetin, R., Roxburgh, A., Dobbins, T., Farrell, M., Burns, L., & Hall, W. D. (2017). Crystalline methamphetamine use and methamphetamine-related harms in Australia. Drug and Alcohol Review, 36(2), 160–170. https://doi.org/10.1111/dar.12426
   PubMed Web of Science ®Google Scholar
• Douglass, C. H., Early, E. C., Wright, C. J. C., Palmer, A., Higgs, P., Quinn, B., Dietze, P. M., & Lim, M. S. C. (2017). “Just not all ice users do that”: investigating perceptions and potential harms of Australia’s Ice Destroys Lives campaign in two studies. Harm Reduction Journal, 14(1), 45. https://doi.org/10.1186/s12954-017-0175-9
   PubMedGoogle Scholar
• Farrugia, A., Fraser, S., Edwards, M., Madden, A., & Hocking, S. (2019). Lived experiences of stigma and discrimination among people accessing. South Western Sydney Local Health District Drug Health.
   Google Scholar
• FitzGerald, C., & Hurst, S. (2017). Implicit bias in healthcare professionals: a systematic review. BMC Medical Ethics, 18(1), 19. https://doi.org/10.1186/s12910-017-0179-8
   PubMed Web of Science ®Google Scholar
• Foster, A. A., Daly, C. J., Logan, T., Logan, R., Jarvis, H., Croce, J., Jalal, Z., Trygstad, T., Bowers, D., Clark, B., Moore, S., & Jacobs, D. M. (2021). Addressing social determinants of health in community pharmacy: Innovative opportunities and practice models. Journal of the American Pharmacists Association, 61(5), e48–e54. https://doi.org/10.1016/j.japh.2021.04.022
   PubMed Web of Science ®Google Scholar
• Francis, M., Manning, V., & Cheetham, A. (2020). Exploring stigmatizing attitudes among community mental health clinicians working with clients who have a dual diagnosis. International Journal of Mental Health and Addiction, 18(5), 1437–1445. https://doi.org/10.1007/s11469-019-00171-5
   Web of Science ®Google Scholar
• Garcia-Cardenas, V., Rossing, C. V., Fernandez-Llimos, F., Schulz, M., Tsuyuki, R., Bugnon, O., Stumpf Tonin, F., & Benrimoj, S. I. (2020). Pharmacy practice research – A call to action. Research in Social and Administrative Pharmacy, 16(11), 1602–1608. https://doi.org/10.1016/j.sapharm.2020.07.031
   PubMed Web of Science ®Google Scholar
• Gilchrist, G., Moskalewicz, J., Slezakova, S., Okruhlica, L., Torrens, M., Vajd, R., & Baldacchino, A. (2011). Staff regard towards working with substance users: a European multi-centre study. Addiction, 106(6), 1114–1125. https://doi.org/10.1111/j.1360-0443.2011.03407.x
   PubMed Web of Science ®Google Scholar
• Hall, N. Y., Le, L., Majmudar, I., & Mihalopoulos, C. (2021). Barriers to accessing opioid substitution treatment for opioid use disorder: A systematic review from the client perspective. Drug and Alcohol Dependence, 221, 108651. https://doi.org/10.1016/j.drugalcdep.2021.108651
   PubMed Web of Science ®Google Scholar
• Hatzenbuehler, M. L., & Link, B. G. (2014). Introduction to the special issue on structural stigma and health. Social Science & Medicine, 103, 1–6. https://doi.org/10.1016/j.socscimed.2013.12.017
   PubMed Web of Science ®Google Scholar
• Health, A. I. o., & Welfare. (2020). National Drug strategy household survey 2019. https://www.aihw.gov.au/reports/illicit-use-of-drugs/national-drug-strategy-household-survey-2019
   Google Scholar
• Health, A. I. o., & Welfare. (2022). National opioid pharmacotherapy statistics annual data collection. https://www.aihw.gov.au/reports/alcohol-other-drug-treatment-services/national-opioid-pharmacotherapy-statistics
   Google Scholar
• Health, A. I. o., & Welfare. (2023). Alcohol, tobacco & other drugs in Australia. https://www.aihw.gov.au/reports/alcohol/alcohol-tobacco-other-drugs-australia
   Google Scholar
• Horner, G., Daddona, J., Burke, D. J., Cullinane, J., Skeer, M., & Wurcel, A. G. (2019). “You’re kind of at war with yourself as a nurse”: Perspectives of inpatient nurses on treating people who present with a comorbid opioid use disorder. PLoS One, 14(10), e0224335. https://doi.org/10.1371/journal.pone.0224335
   PubMed Web of Science ®Google Scholar
• Hurley-Kim, K., Unonu, J., Wisseh, C., Cadiz, C., Knox, E., Ozaki, A. F., & Chan, A. (2022). Health disparities in pharmacy practice within the community: Let's brainstorm for solutions. Frontiers in Public Health, 10, 847696. https://doi.org/10.3389/fpubh.2022.847696
   PubMed Web of Science ®Google Scholar
• Kelly, D., Hyde, S., & Abdalla, M. E. (2022). Mapping health, social and health system issues and applying a social accountability inventory to a problem based learning medical curriculum. Medical Education Online, 27(1), 2016243. https://doi.org/10.1080/10872981.2021.2016243
   PubMed Web of Science ®Google Scholar
• Kiles, T. M., Peroulas, D., & Borja-Hart, N. (2022). Defining the role of pharmacists in addressing the social determinants of health. Research in Social and Administrative Pharmacy, 18(9), 3699–3703. https://doi.org/10.1016/j.sapharm.2022.01.005
   PubMed Web of Science ®Google Scholar
• Lea, T., Sheridan, J., & Winstock, A. (2008). Consumer satisfaction with opioid treatment services at community pharmacies in Australia. Pharmacy World & Science, 30(6), 940–946. https://doi.org/10.1007/s11096-008-9257-9
   PubMedGoogle Scholar
• Lee, W. C., Chang, H. M., Huang, M. C., Pan, C. H., Su, S. S., Tsai, S. Y., Chen, C. C., & Kuo, C. J. (2022). Increased medical utilization and psychiatric comorbidity following a new diagnosis of methamphetamine use disorder. The American Journal of Drug and Alcohol Abuse, 48(2), 245–254. https://doi.org/10.1080/00952990.2021.1979990
   PubMed Web of Science ®Google Scholar
• Leidl, D., Takhar, P., & Li, H. (2023). Prescription psychostimulants as a harm reduction and treatment intervention for methamphetamine use disorder and the implications for nursing clinical practice: A scoping review of the literature. International Journal of Mental Health Nursing, 32(5), 1225–1242. https://doi.org/10.1111/inm.13144
   PubMed Web of Science ®Google Scholar
• Link, B. G., & Phelan, J. C. (2001). Conceptualizing stigma. Annual Review of Sociology, 27(1), 363–385. https://doi.org/10.1146/annurev.soc.27.1.363
   Web of Science ®Google Scholar
• Livingston, J. (2020). Structural stigma in health-care contexts for people with mental health and substance use issues: A literature review. https://doi.org/10.13140/RG.2.2.21168.17929
   Google Scholar
• Livingston, J. D., Milne, T., Fang, M. L., & Amari, E. (2012). The effectiveness of interventions for reducing stigma related to substance use disorders: a systematic review. Addiction, 107(1), 39–50. https://doi.org/10.1111/j.1360-0443.2011.03601.x
   PubMed Web of Science ®Google Scholar
• Lloyd, C. (2013). The stigmatization of problem drug users: A narrative literature review. Drugs: Education, Prevention and Policy, 20(2), 85–95. https://doi.org/10.3109/09687637.2012.743506
   Web of Science ®Google Scholar
• Mahon, L. R., Hawthorne, A. N., Lee, J., Blue, H., & Palombi, L. (2018). Assessing pharmacy student experience with, knowledge of and attitudes towards harm reduction: illuminating barriers to pharmacist-led harm reduction. Harm Reduction Journal, 15(1), 57. https://doi.org/10.1186/s12954-018-0262-6
   PubMedGoogle Scholar
• Maina, I. W., Belton, T. D., Ginzberg, S., Singh, A., & Johnson, T. J. (2018). A decade of studying implicit racial/ethnic bias in healthcare providers using the implicit association test. Social Science & Medicine, 199, 219–229. https://doi.org/10.1016/j.socscimed.2017.05.009
   PubMed Web of Science ®Google Scholar
• McKetin, R., Degenhardt, L., Shanahan, M., Baker, A. L., Lee, N. K., & Lubman, D. I. (2018). Health service utilisation attributable to methamphetamine use in Australia: Patterns, predictors and national impact. Drug and Alcohol Review, 37(2), 196–204. https://doi.org/10.1111/dar.12518
   PubMed Web of Science ®Google Scholar
• McKetin, R., Kelly, E., & McLaren, J. (2006). The relationship between crystalline methamphetamine use and methamphetamine dependence. Drug and Alcohol Dependence, 85(3), 198–204. https://doi.org/10.1016/j.drugalcdep.2006.04.007
   PubMed Web of Science ®Google Scholar
• NVivo. (2020). NVivo. In QSR International Pty Ltd. https://www.qsrinternational.com/nvivo-qualitative-data-analysis-software/home
   Google Scholar
• Nyblade, L., Stockton, M. A., Giger, K., Bond, V., Ekstrand, M. L., Lean, R. M., Mitchell, E. M. H., Nelson, R. E., Sapag, J. C., Siraprapasiri, T., Turan, J., & Wouters, E. (2019). Stigma in health facilities: why it matters and how we can change it. BMC Medicine, 17(1), 25. https://doi.org/10.1186/s12916-019-1256-2
   PubMed Web of Science ®Google Scholar
• Otter.ai. (2023). Otter.
   Google Scholar
• Parker, R., & Aggleton, P. (2003). HIV and AIDS-related stigma and discrimination: a conceptual framework and implications for action. Social Science & Medicine, 57(1), 13–24. https://doi.org/10.1016/S0277-9536(02)00304-0
   PubMed Web of Science ®Google Scholar
• Peris, T. S., Teachman, B. A., & Nosek, B. A. (2008). Implicit and explicit stigma of mental illness: links to clinical care. Journal of Nervous & Mental Disease, 196(10), 752–760. https://doi.org/10.1097/NMD.0b013e3181879dfd
   PubMed Web of Science ®Google Scholar
• Radley, A., Melville, K., Easton, P., Williams, B., & Dillon, J. F. (2016). ‘Standing Outside the Junkie Door’—service users’ experiences of using community pharmacies to access treatment for opioid dependency. Journal of Public Health, 39(4), 846–855. https://doi.org/10.1093/pubmed/fdw138
   Web of Science ®Google Scholar
• Rawstorne, P., O'Connor, R., Cohn, A., Fredrickson, A., Jayasinha, R., Hayen, A., Lancaster, K., & Nathan, S. (2020). Australian news media reporting of methamphetamine: an analysis of print media 2014–2016. Australian and New Zealand Journal of Public Health, 44(6), 468–475. https://doi.org/10.1111/1753-6405.13030
   PubMed Web of Science ®Google Scholar
• Richards, L. (2005). Handling qualitative data: A practical guide.
   Google Scholar
• Saka, S. A., Adisa, R., Isah, A., & Biambo, A. A. (2021). Pharmacy graduates’ perceptions of competency, integration, and social accountability in the undergraduate curriculum of pharmacy schools in Nigeria. Currents in Pharmacy Teaching and Learning, 13(11), 1414–1423. https://doi.org/10.1016/j.cptl.2021.09.005
   PubMed Web of Science ®Google Scholar
• Siefried, K. J., Acheson, L. S., Lintzeris, N., & Ezard, N. (2020). Pharmacological treatment of methamphetamine/amphetamine dependence: A systematic review. CNS Drugs, 34(4), 337–365. https://doi.org/10.1007/s40263-020-00711-x
   PubMed Web of Science ®Google Scholar
• Srivastava, P., & Hopwood, N. (2009). A practical iterative framework for qualitative data analysis. International Journal of Qualitative Methods, 8(1), 76–84. https://doi.org/10.1177/160940690900800107
   Google Scholar
• Stangl, A. L., Earnshaw, V. A., Logie, C. H., van Brakel, W., Simbayi, C., Barré, L., Dovidio, I., & F, J. (2019). The Health Stigma and Discrimination Framework: a global, crosscutting framework to inform research, intervention development, and policy on health-related stigmas. BMC Medicine, 17(1), 31. https://doi.org/10.1186/s12916-019-1271-3
   PubMed Web of Science ®Google Scholar
• Stone, E. M., Kennedy-Hendricks, A., Barry, C. L., Bachhuber, M. A., & McGinty, E. E. (2021). The role of stigma in U.S. primary care physicians’ treatment of opioid use disorder. Drug and Alcohol Dependence, 221, 108627. https://doi.org/10.1016/j.drugalcdep.2021.108627
   PubMed Web of Science ®Google Scholar
• Strauss, A., & Corbin, J. (1998). Basics of qualitative research techniques.
   Google Scholar
• Stupans, I., Atkinson, J., Meštrović, A., Nash, R., & Rouse, M. J. (2016). A shared focus: Comparing the Australian, Canadian, United Kingdom and United States pharmacy learning outcome frameworks and the global competency framework. Pharmacy, 4(3), 26. https://doi.org/10.3390/pharmacy4030026
   Google Scholar
• Subu, M. A., Wati, D. F., Netrida, N., Priscilla, V., Dias, J. M., Abraham, M. S., Slewa-Younan, S., & Al-Yateem, N. (2021). Types of stigma experienced by patients with mental illness and mental health nurses in Indonesia: a qualitative content analysis. International Journal of Mental Health Systems, 15(1), 77. https://doi.org/10.1186/s13033-021-00502-x
   PubMed Web of Science ®Google Scholar
• UNODC. (2022). World Drug Report 2022.
   Google Scholar
• van Boekel, L. C., Brouwers, E. P., van Weeghel, J., & Garretsen, H. F. (2013). Stigma among health professionals towards patients with substance use disorders and its consequences for healthcare delivery: systematic review. Drug and Alcohol Dependence, 131(1-2), 23–35. https://doi.org/10.1016/j.drugalcdep.2013.02.018
   PubMed Web of Science ®Google Scholar
• Wallace, B., van Roode, T., Pagan, F., Phillips, P., Wagner, H., Calder, S., Aasen, J., Pauly, B., & Hore, D. (2020). What is needed for implementing drug checking services in the context of the overdose crisis? A qualitative study to explore perspectives of potential service users. Harm Reduction Journal, 17(1), 29. https://doi.org/10.1186/s12954-020-00373-4
   PubMed Web of Science ®Google Scholar
• Wenger, L. M., Rosenthal, M., Sharpe, J. P., & Waite, N. (2016). Confronting inequities: A scoping review of the literature on pharmacist practice and health-related disparities. Research in Social and Administrative Pharmacy, 12(2), 175–217. https://doi.org/10.1016/j.sapharm.2015.05.011
   PubMed Web of Science ®Google Scholar
• Werremeyer, A., Mosher, S., Eukel, H., Skoy, E., Steig, J., Frenzel, O., & Strand, M. A. (2021). Pharmacists’ stigma toward patients engaged in opioid misuse: When “social distance” does not mean disease prevention. Substance Abuse, 42(4), 919–926. https://doi.org/10.1080/08897077.2021.1900988
   PubMed Web of Science ®Google Scholar
• Zestcott, C. A., Blair, I. V., & Stone, J. (2016). Examining the presence, consequences, and reduction of implicit bias in health care: A narrative review. Group Processes & Intergroup Relations, 19(4), 528–542. https://doi.org/10.1177/1368430216642029
   PubMed Web of Science ®Google Scholar